MIRCERA Trademark

Trademark Overview

On Wednesday, September 24, 2003, a trademark application was filed for MIRCERA with the United States Patent and Trademark Office. The USPTO has given the MIRCERA trademark a serial number of 78304603. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 6, 2013. This trademark is owned by Hoffmann-La Roche Inc.. The MIRCERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment of renal anemia in patients with chronic renal failure, chronic kidney diseases, hemodialysis, peritoneal dialysis, treatment of cancer-associated anemia, HIV-associated anemia and transfusion avoidance

General Information

Serial Number78304603
Word MarkMIRCERA
Filing DateWednesday, September 24, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 6, 2013
Registration Number3237894
Registration DateTuesday, May 1, 2007
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 13, 2004

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment of renal anemia in patients with chronic renal failure, chronic kidney diseases, hemodialysis, peritoneal dialysis, treatment of cancer-associated anemia, HIV-associated anemia and transfusion avoidance

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 6, 2013
Primary Code005
First Use Anywhere DateMonday, October 30, 2006
First Use In Commerce DateMonday, October 30, 2006

Trademark Owner History

Party NameHoffmann-La Roche Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNutley, NJ 07110
Party NameHoffmann-La Roche Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNutley, NJ 07110
Party NameHoffmann-La Roche Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNutley, NJ 07110

Trademark Events

Event DateEvent Description
Friday, December 6, 2013CANCELLED SEC. 8 (6-YR)
Wednesday, November 18, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 18, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 1, 2007REGISTERED-PRINCIPAL REGISTER
Wednesday, March 21, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, March 17, 2007ASSIGNED TO LIE
Thursday, February 22, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, January 27, 2007STATEMENT OF USE PROCESSING COMPLETE
Saturday, January 27, 2007EXTENSION 5 GRANTED
Tuesday, November 21, 2006USE AMENDMENT FILED
Tuesday, November 21, 2006EXTENSION 5 FILED
Tuesday, November 21, 2006TEAS EXTENSION RECEIVED
Tuesday, November 21, 2006TEAS STATEMENT OF USE RECEIVED
Monday, September 25, 2006EXTENSION 4 GRANTED
Wednesday, August 30, 2006EXTENSION 4 FILED
Wednesday, August 30, 2006TEAS EXTENSION RECEIVED
Thursday, March 16, 2006EXTENSION 3 GRANTED
Tuesday, February 28, 2006EXTENSION 3 FILED
Tuesday, February 28, 2006TEAS EXTENSION RECEIVED
Wednesday, September 7, 2005EXTENSION 2 GRANTED
Thursday, August 25, 2005EXTENSION 2 FILED
Thursday, August 25, 2005TEAS EXTENSION RECEIVED
Thursday, March 24, 2005EXTENSION 1 GRANTED
Thursday, March 24, 2005EXTENSION 1 FILED
Thursday, March 24, 2005TEAS EXTENSION RECEIVED
Tuesday, October 5, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 13, 2004PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2004NOTICE OF PUBLICATION
Sunday, May 2, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 5, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 5, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 31, 2004NON-FINAL ACTION E-MAILED
Tuesday, March 30, 2004ASSIGNED TO EXAMINER

Related Keywords

mircera anemia chronic associated renal treatment cancer dialysis transfusion peritoneal avoidance